{"product_id":"global-adeno-associated-virus-aav-gene-therapy-supply-demand-and-key-producers-2023-2029","title":"Global Adeno-Associated Virus (AAV) Gene Therapy Supply, Demand and Key Producers, 2023-2029","description":"\u003cp\u003eGlobal Adeno-Associated Virus (AAV) Gene Therapy Supply, Demand and Key Producers, 2023-2029\u003cbr\u003e\nThe global Adeno-Associated Virus (AAV) Gene Therapy market size is expected to reach $ 2966.6 million by 2029, rising at a market growth of 8.4% CAGR during the forecast period (2023-2029).\u003c\/p\u003e\n\n\u003cp\u003eThis report studies the global Adeno-Associated Virus (AAV) Gene Therapy demand, key companies, and key regions.\u003c\/p\u003e\n\n\u003cp\u003eThis report is a detailed and comprehensive analysis of the world market for Adeno-Associated Virus (AAV) Gene Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Adeno-Associated Virus (AAV) Gene Therapy that contribute to its increasing demand across many markets.\u003c\/p\u003e\n\n\u003cp\u003eHighlights and key features of the study\u003c\/p\u003e\n\n\u003cp\u003eGlobal Adeno-Associated Virus (AAV) Gene Therapy total market, 2018-2029, (USD Million)\u003c\/p\u003e\n\n\u003cp\u003eGlobal Adeno-Associated Virus (AAV) Gene Therapy total market by region \u0026amp; country, CAGR, 2018-2029, (USD Million)\u003c\/p\u003e\n\n\u003cp\u003eU.S. VS China: Adeno-Associated Virus (AAV) Gene Therapy total market, key domestic companies and share, (USD Million)\u003c\/p\u003e\n\n\u003cp\u003eGlobal Adeno-Associated Virus (AAV) Gene Therapy revenue by player and market share 2018-2023, (USD Million)\u003c\/p\u003e\n\n\u003cp\u003eGlobal Adeno-Associated Virus (AAV) Gene Therapy total market by Type, CAGR, 2018-2029, (USD Million)\u003c\/p\u003e\n\n\u003cp\u003eGlobal Adeno-Associated Virus (AAV) Gene Therapy total market by Application, CAGR, 2018-2029, (USD Million)\u003c\/p\u003e\n\n\u003cp\u003eThis reports profiles major players in the global Adeno-Associated Virus (AAV) Gene Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Creative Biolabs, Affinia Therapeutics, Spark Therapeutics, AGC Biologics, StrideBio, SIRION Biotech, Neurophth Biotechnology, Belief BioMed and BiBo Biopharma Engineering Co., LTD., etc.\u003c\/p\u003e\n\n\u003cp\u003eThis report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.\u003c\/p\u003e\n\n\u003cp\u003eStakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Adeno-Associated Virus (AAV) Gene Therapy market\u003c\/p\u003e\n\n\u003cp\u003eDetailed Segmentation:\u003c\/p\u003e\n\n\u003cp\u003eEach section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.\u003c\/p\u003e\n\n\u003cp\u003eGlobal Adeno-Associated Virus (AAV) Gene Therapy Market, By Region:\u003cbr\u003e\nUnited States\u003cbr\u003e\nChina\u003cbr\u003e\nEurope\u003cbr\u003e\nJapan\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nASEAN\u003cbr\u003e\nIndia\u003cbr\u003e\nRest of World\u003c\/p\u003e\n\n\u003cp\u003eGlobal Adeno-Associated Virus (AAV) Gene Therapy Market, Segmentation by Type\u003cbr\u003e\nLuxturna\u003cbr\u003e\nZolgensma\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eGlobal Adeno-Associated Virus (AAV) Gene Therapy Market, Segmentation by Application\u003cbr\u003e\nCentral Nervous System Diseases\u003cbr\u003e\nOcular Diseases\u003cbr\u003e\nLiver-directed Diseases\u003cbr\u003e\nOther Hereditary Diseases\u003c\/p\u003e\n\n\u003cp\u003eCompanies Profiled:\u003cbr\u003e\nCreative Biolabs\u003cbr\u003e\nAffinia Therapeutics\u003cbr\u003e\nSpark Therapeutics\u003cbr\u003e\nAGC Biologics\u003cbr\u003e\nStrideBio\u003cbr\u003e\nSIRION Biotech\u003cbr\u003e\nNeurophth Biotechnology\u003cbr\u003e\nBelief BioMed\u003cbr\u003e\nBiBo Biopharma Engineering Co., LTD.\u003cbr\u003e\nBeihai Kangcheng\u003cbr\u003e\nPackGene Biotech\u003cbr\u003e\nSarepta Therapeutics\u003cbr\u003e\nCarbon BioSciences\u003cbr\u003e\nKelonia Therapeutics\u003cbr\u003e\nRoche\u003cbr\u003e\nRemedium Bio\u003c\/p\u003e\n\n\u003cp\u003eKey Questions Answered\u003c\/p\u003e\n\n\u003cp\u003e1. How big is the global Adeno-Associated Virus (AAV) Gene Therapy market?\u003c\/p\u003e\n\n\u003cp\u003e2. What is the demand of the global Adeno-Associated Virus (AAV) Gene Therapy market?\u003c\/p\u003e\n\n\u003cp\u003e3. What is the year over year growth of the global Adeno-Associated Virus (AAV) Gene Therapy market?\u003c\/p\u003e\n\n\u003cp\u003e4. What is the total value of the global Adeno-Associated Virus (AAV) Gene Therapy market?\u003c\/p\u003e\n\n\u003cp\u003e5. Who are the major players in the global Adeno-Associated Virus (AAV) Gene Therapy market?\u003c\/p\u003e\n\n\u003cp\u003e6. What are the growth factors driving the market demand?\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"July, 2023 \/ 123 Pages \/ MCW16231116","offer_id":47647266242866,"sku":null,"price":5376.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-adeno-associated-virus-aav-gene-therapy-supply-demand-and-key-producers-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}